Cangrelor (tetrasodium)
CAS No. : 163706-36-3
(Synonyms: AR-C69931MX (tetrasodium))
| Size | Price | Stock |
|---|---|---|
| 5mg | $115 | In-stock |
| 10mg | $175 | In-stock |
| 50mg | $550 | In-stock |
| 100mg | $780 | In-stock |
| 500mg | $1600 | In-stock |
| 1 g | Get quote | |
| 5 g | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-19638A |
| M.Wt: | 864.29 |
| Formula: | C17H21Cl2F3N5Na4O12P3S2 |
| Purity: | >98 % |
| Solubility: | H2O : 125 mg/mL (ultrasonic);DMSO : 12.5 mg/mL (ultrasonic;warming;heat to 80°C) |
Cangrelor tetrasodium, an adenosine triphosphate analogue, is a reversible and selective platelet P2Y12 antagonist, with prompt and potent antiplatelet effects. Cangrelor tetrasodium directly blocks adenosine diphosphate (ADP)-induced activation and aggregation of platelets. Cangrelor tetrasodium is also a nonspecific GPR17 antagonist[1][2].
In Vitro: Cangrelor tetrasodium is the only potent intravenous direct and specific adenosine diphosphate (ADP) P2Y12 receptor antagonist[1].
Cangrelor tetrasodium has pKb of 8.6-9.2 for hP2Y12 receptor[3].
In Vivo: Cangrelor tetrasodium (10 mg/kg) not only significantly decreases BLM-induced release of inflammatory cytokines (PF4, CD40 L and MPO), but also decreases the increment of platelets, neutrophils and platelet-neutrophil aggregates in the fibrotic lung and in the peripheral blood of BLM-treated mice[2].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information- Product Name:
- Cangrelor (tetrasodium)
- Cat. No.:
- HY-19638A
- Quantity:
Your information is safe with us.